RecruitingNot ApplicableNCT07016425
Temporal Interference for Essential Tremor
Efficacy and Safety of Non-invasive Temporal Interference Stimulation in the Treatment of Essential Tremor: A Pilot Trial
Sponsor
Liankun_Ren
Enrollment
10 participants
Start Date
Jun 9, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.
Eligibility
Min Age: 30 YearsMax Age: 70 Years
Inclusion Criteria3
- Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb;
- No history of mental diseases;
- Informed consent signed.
Exclusion Criteria7
- Presence of other neurological diseases affecting the study (such as epilepsy);
- Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points);
- Orthopedic diseases that may affect motor symptoms;
- Patients taking antipsychotic or antidepressant medications;
- Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers);
- History of electroconvulsive therapy;
- Presence of cardiovascular risk factors, etc.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERTemporal Interference
Researchers apply temporal interference (TI) stimulation to the deep brain nuclei of essential tremor patients.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07016425
Related Trials
Magnetoencephalography (MEG) Pilot Study
NCT074461921 location
Deep Brain Stimulation Surgery for Movement Disorders
NCT015815801 location
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
NCT065536254 locations
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
NCT0403247020 locations
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT0366460919 locations